ArticleThe oncologist2021

Adoptive Transfer of Autologous Invariant Natural Killer T Cells as Immunotherapy for Advanced Hepatocellular Carcinoma: A Phase I Clinical Trial.

Yao Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.